fanta.bio Sample: CNhs11323
- Species
- human
- CRE Type
- ELA
- Cluster
- 2
- Cell Type Class
- Digestive_tract
12550 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 957 / 6462 (14.8%) | 186 / 64620 (0.3%) | −324.0 | −324.0 | 51.45 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1351 / 6462 (20.9%) | 345 / 64620 (0.5%) | −324.0 | −324.0 | 39.16 |
| HIF1A SRX11007095 | HK-2 Kidney | 1055 / 6462 (16.3%) | 493 / 64620 (0.8%) | −324.0 | −324.0 | 21.40 |
| SCML2 SRX644728 | 293 Kidney | 751 / 6462 (11.6%) | 372 / 64620 (0.6%) | −324.0 | −324.0 | 20.19 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 825 / 6462 (12.8%) | 426 / 64620 (0.7%) | −324.0 | −324.0 | 19.37 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 1123 / 6462 (17.4%) | 602 / 64620 (0.9%) | −324.0 | −324.0 | 18.65 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 1091 / 6462 (16.9%) | 603 / 64620 (0.9%) | −324.0 | −324.0 | 18.09 |
| MED1 SRX9419945 | BT-474 Breast | 1620 / 6462 (25.1%) | 1398 / 64620 (2.2%) | −324.0 | −324.0 | 11.59 |
| MED1 SRX9419944 | BT-474 Breast | 1581 / 6462 (24.5%) | 1380 / 64620 (2.1%) | −324.0 | −324.0 | 11.46 |
| BRD4 SRX9419936 | BT-474 Breast | 1627 / 6462 (25.2%) | 1441 / 64620 (2.2%) | −324.0 | −324.0 | 11.29 |
| MED1 SRX9419947 | BT-474 Breast | 1597 / 6462 (24.7%) | 1426 / 64620 (2.2%) | −324.0 | −324.0 | 11.20 |
| BRD4 SRX9419935 | BT-474 Breast | 1572 / 6462 (24.3%) | 1407 / 64620 (2.2%) | −324.0 | −324.0 | 11.17 |
| MED1 SRX9419946 | BT-474 Breast | 1625 / 6462 (25.1%) | 1458 / 64620 (2.3%) | −324.0 | −324.0 | 11.15 |
| BRD4 SRX9419938 | BT-474 Breast | 1590 / 6462 (24.6%) | 1454 / 64620 (2.3%) | −324.0 | −324.0 | 10.94 |
| BRD4 SRX9419937 | BT-474 Breast | 1544 / 6462 (23.9%) | 1426 / 64620 (2.2%) | −324.0 | −324.0 | 10.83 |
| FOXP1 SRX736067 | LNCAP Prostate | 662 / 6462 (10.2%) | 619 / 64620 (1.0%) | −324.0 | −324.0 | 10.69 |
| BRD4 SRX736201 | 90-8TL Neural | 2776 / 6462 (43.0%) | 2959 / 64620 (4.6%) | −324.0 | −324.0 | 9.38 |
| EZH2 SRX2146136 | LNCAP Prostate | 3387 / 6462 (52.4%) | 3754 / 64620 (5.8%) | −324.0 | −324.0 | 9.02 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 792 / 6462 (12.3%) | 1151 / 64620 (1.8%) | −318.5 | −315.3 | 6.88 |
| 5-mC SRX882970 | LNCAP Prostate | 1721 / 6462 (26.6%) | 5877 / 64620 (9.1%) | −318.2 | −315.0 | 2.93 |
| 5-mC SRX882968 | LNCAP Prostate | 1683 / 6462 (26.0%) | 5819 / 64620 (9.0%) | −304.6 | −301.4 | 2.89 |
| RUNX1 SRX2513054 | 293 Kidney | 1804 / 6462 (27.9%) | 6869 / 64620 (10.6%) | −284.6 | −281.5 | 2.63 |
| 5-mC SRX882965 | LNCAP Prostate | 1420 / 6462 (22.0%) | 4526 / 64620 (7.0%) | −281.0 | −277.9 | 3.14 |
| AGO2 SRX4708039 | Hep G2 Liver | 1077 / 6462 (16.7%) | 2948 / 64620 (4.6%) | −250.5 | −247.4 | 3.65 |
| CIC SRX13262055 | Astrocytes Neural | 1632 / 6462 (25.3%) | 6452 / 64620 (10.0%) | −237.6 | −234.5 | 2.53 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 1165 / 6462 (18.0%) | 3754 / 64620 (5.8%) | −222.1 | −219.0 | 3.10 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 426 / 6462 (6.6%) | 394 / 64620 (0.6%) | −219.6 | −216.5 | 10.81 |
| TRP47 SRX4548329 | THP-1 Blood | 1387 / 6462 (21.5%) | 5345 / 64620 (8.3%) | −205.7 | −202.6 | 2.59 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 807 / 6462 (12.5%) | 2066 / 64620 (3.2%) | −198.5 | −195.4 | 3.91 |
| Epitope tags SRX10549776 | K-562 Blood | 805 / 6462 (12.5%) | 2060 / 64620 (3.2%) | −198.0 | −195.0 | 3.91 |
| TP53 SRX19538279 | Osteoblasts Bone | 283 / 6462 (4.4%) | 138 / 64620 (0.2%) | −188.4 | −185.3 | 20.51 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 953 / 6462 (14.7%) | 2980 / 64620 (4.6%) | −185.9 | −182.9 | 3.20 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 266 / 6462 (4.1%) | 114 / 64620 (0.2%) | −184.3 | −181.3 | 23.33 |
| MITF SRX1555436 | 501A Epidermis | 1061 / 6462 (16.4%) | 3631 / 64620 (5.6%) | −183.8 | −180.9 | 2.92 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 987 / 6462 (15.3%) | 3259 / 64620 (5.0%) | −179.2 | −176.2 | 3.03 |
| SREBF2 SRX5359048 | HCC70 Breast | 932 / 6462 (14.4%) | 2944 / 64620 (4.6%) | −179.1 | −176.1 | 3.17 |
| MYH11 SRX265221 | ME-1 Blood | 343 / 6462 (5.3%) | 308 / 64620 (0.5%) | −178.9 | −175.9 | 11.14 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 905 / 6462 (14.0%) | 2811 / 64620 (4.4%) | −177.5 | −174.5 | 3.22 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 319 / 6462 (4.9%) | 255 / 64620 (0.4%) | −175.6 | −172.7 | 12.51 |
| TP53 SRX19538274 | U2OS Bone | 239 / 6462 (3.7%) | 91 / 64620 (0.1%) | −171.2 | −168.3 | 26.26 |
| WDR5 SRX5416008 | SMMC-7721 Liver | 954 / 6462 (14.8%) | 3224 / 64620 (5.0%) | −166.9 | −164.0 | 2.96 |
| RUNX1 SRX2014504 | Jurkat Blood | 1230 / 6462 (19.0%) | 4964 / 64620 (7.7%) | −165.9 | −163.0 | 2.48 |
| BMI1 SRX7196721 | SF8628 Neural | 920 / 6462 (14.2%) | 3052 / 64620 (4.7%) | −165.0 | −162.1 | 3.01 |
| MECOM SRX23677885 | HNT-34 Blood | 936 / 6462 (14.5%) | 3153 / 64620 (4.9%) | −164.4 | −161.5 | 2.97 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 1004 / 6462 (15.5%) | 3564 / 64620 (5.5%) | −163.9 | −161.1 | 2.82 |
| MECOM SRX23677884 | HNT-34 Blood | 930 / 6462 (14.4%) | 3128 / 64620 (4.8%) | −163.5 | −160.7 | 2.97 |
| PTEN SRX5416007 | SMMC-7721 Liver | 946 / 6462 (14.6%) | 3245 / 64620 (5.0%) | −161.9 | −159.0 | 2.92 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 314 / 6462 (4.9%) | 289 / 64620 (0.4%) | −161.6 | −158.8 | 10.87 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 988 / 6462 (15.3%) | 3514 / 64620 (5.4%) | −160.7 | −157.9 | 2.81 |
| MECOM SRX23677897 | HNT-34 Blood | 1060 / 6462 (16.4%) | 3965 / 64620 (6.1%) | −160.0 | −157.2 | 2.67 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 626 / 6462 (9.7%) | 1535 / 64620 (2.4%) | −159.4 | −156.6 | 4.08 |
| CDYL2 SRX8321653 | MCF-7 Breast | 948 / 6462 (14.7%) | 3300 / 64620 (5.1%) | −158.8 | −156.0 | 2.87 |
| MECOM SRX23677896 | HNT-34 Blood | 1088 / 6462 (16.8%) | 4164 / 64620 (6.4%) | −158.7 | −155.9 | 2.61 |
| TP53 SRX19538280 | Osteoblasts Bone | 233 / 6462 (3.6%) | 106 / 64620 (0.2%) | −158.4 | −155.6 | 21.98 |
| TP53 SRX19538268 | U2OS Bone | 227 / 6462 (3.5%) | 98 / 64620 (0.2%) | −156.8 | −154.0 | 23.16 |
| BRD4 SRX736204 | 90-8TL Neural | 525 / 6462 (8.1%) | 1108 / 64620 (1.7%) | −154.2 | −151.5 | 4.74 |
| TP53 SRX19538276 | U2OS Bone | 224 / 6462 (3.5%) | 98 / 64620 (0.2%) | −154.1 | −151.3 | 22.86 |
| TP53 SRX19538275 | U2OS Bone | 217 / 6462 (3.4%) | 91 / 64620 (0.1%) | −151.2 | −148.4 | 23.85 |
| TP53 SRX19538281 | Osteoblasts Bone | 239 / 6462 (3.7%) | 142 / 64620 (0.2%) | −148.4 | −145.7 | 16.83 |
| AGO2 SRX6783958 | Hep G2 Liver | 648 / 6462 (10.0%) | 1751 / 64620 (2.7%) | −148.3 | −145.6 | 3.70 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 335 / 6462 (5.2%) | 411 / 64620 (0.6%) | −147.2 | −144.4 | 8.15 |
| AGO2 SRX6783957 | Hep G2 Liver | 656 / 6462 (10.2%) | 1805 / 64620 (2.8%) | −147.1 | −144.3 | 3.63 |
| IRF3 SRX11453858 | Hep G2 Liver | 188 / 6462 (2.9%) | 51 / 64620 (0.1%) | −146.3 | −143.6 | 36.86 |
| TP53 SRX19538273 | U2OS Bone | 206 / 6462 (3.2%) | 81 / 64620 (0.1%) | −146.2 | −143.5 | 25.43 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 814 / 6462 (12.6%) | 2696 / 64620 (4.2%) | −145.1 | −142.4 | 3.02 |
| TP53 SRX19538267 | U2OS Bone | 202 / 6462 (3.1%) | 77 / 64620 (0.1%) | −144.6 | −141.9 | 26.23 |
| ERG SRX063922 | K-562 Blood | 812 / 6462 (12.6%) | 2725 / 64620 (4.2%) | −142.0 | −139.3 | 2.98 |
| TP53 SRX19538269 | U2OS Bone | 250 / 6462 (3.9%) | 186 / 64620 (0.3%) | −141.9 | −139.2 | 13.44 |
| TP53 SRX19538271 | U2OS Bone | 350 / 6462 (5.4%) | 507 / 64620 (0.8%) | −138.1 | −135.4 | 6.90 |
| TP53 SRX19538270 | U2OS Bone | 241 / 6462 (3.7%) | 179 / 64620 (0.3%) | −136.9 | −134.2 | 13.46 |
| TET2 SRX2014505 | Jurkat Blood | 1253 / 6462 (19.4%) | 5649 / 64620 (8.7%) | −136.7 | −134.1 | 2.22 |
| Epitope tags SRX8109066 | Gastric cancer cells Digestive tract | 927 / 6462 (14.3%) | 3499 / 64620 (5.4%) | −136.3 | −133.7 | 2.65 |
| RORC SRX5359053 | HCC70 Breast | 647 / 6462 (10.0%) | 1944 / 64620 (3.0%) | −130.0 | −127.4 | 3.33 |
| ERG SRX063921 | K-562 Blood | 760 / 6462 (11.8%) | 2583 / 64620 (4.0%) | −130.0 | −127.3 | 2.94 |
| AR SRX10820653 | LNCAP Prostate | 193 / 6462 (3.0%) | 94 / 64620 (0.1%) | −128.4 | −125.7 | 20.53 |
| YAP1 SRX757325 | H2052 Lung | 215 / 6462 (3.3%) | 7745 / 64620 (12.0%) | −126.8 | −124.2 | 0.28 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 170 / 6462 (2.6%) | 56 / 64620 (0.1%) | −126.4 | −123.8 | 30.36 |
| RORC SRX5359052 | HCC70 Breast | 657 / 6462 (10.2%) | 2050 / 64620 (3.2%) | −125.7 | −123.1 | 3.20 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 677 / 6462 (10.5%) | 2165 / 64620 (3.4%) | −125.5 | −122.9 | 3.13 |
| PBX4 SRX2731658 | PC-3 Prostate | 357 / 6462 (5.5%) | 9955 / 64620 (15.4%) | −125.4 | −122.8 | 0.36 |
| TRIM25 SRX1660872 | Breast cancer cells Breast | 809 / 6462 (12.5%) | 2949 / 64620 (4.6%) | −124.6 | −122.0 | 2.74 |
| IRF3 SRX11453861 | Hep G2 Liver | 160 / 6462 (2.5%) | 44 / 64620 (0.1%) | −124.2 | −121.5 | 36.36 |
| DOT1L SRX10606581 | GIST-T1 Digestive tract | 984 / 6462 (15.2%) | 4068 / 64620 (6.3%) | −124.1 | −121.5 | 2.42 |
| CTCF SRX10975999 | NALM-6 Blood | 1427 / 6462 (22.1%) | 7185 / 64620 (11.1%) | −123.7 | −121.1 | 1.99 |
| RBFOX2 SRX4708034 | Hep G2 Liver | 917 / 6462 (14.2%) | 3652 / 64620 (5.7%) | −123.0 | −120.4 | 2.51 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 828 / 6462 (12.8%) | 3095 / 64620 (4.8%) | −122.7 | −120.2 | 2.68 |
| KAT7 SRX101303 | RKO Digestive tract | 651 / 6462 (10.1%) | 2057 / 64620 (3.2%) | −122.4 | −119.9 | 3.16 |
| YAP1 SRX757326 | H2052 Lung | 181 / 6462 (2.8%) | 6974 / 64620 (10.8%) | −120.5 | −117.9 | 0.26 |
| MECOM SRX23677891 | HNT-34 Blood | 863 / 6462 (13.4%) | 3355 / 64620 (5.2%) | −120.2 | −117.6 | 2.57 |
| BRPF3 SRX796084 | RKO Digestive tract | 712 / 6462 (11.0%) | 2464 / 64620 (3.8%) | −118.1 | −115.5 | 2.89 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 423 / 6462 (6.5%) | 939 / 64620 (1.5%) | −117.8 | −115.3 | 4.50 |
| SREBF2 SRX5359049 | HCC70 Breast | 606 / 6462 (9.4%) | 1869 / 64620 (2.9%) | −117.4 | −114.8 | 3.24 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 295 / 6462 (4.6%) | 425 / 64620 (0.7%) | −116.6 | −114.1 | 6.94 |
| RBFOX2 SRX4708082 | K-562 Blood | 1079 / 6462 (16.7%) | 4887 / 64620 (7.6%) | −114.6 | −112.1 | 2.21 |
| BRD1 SRX286203 | RKO Digestive tract | 560 / 6462 (8.7%) | 1652 / 64620 (2.6%) | −114.6 | −112.0 | 3.39 |
| MECOM SRX23677890 | HNT-34 Blood | 851 / 6462 (13.2%) | 3383 / 64620 (5.2%) | −113.9 | −111.3 | 2.52 |
| AR SRX10820651 | LNCAP Prostate | 196 / 6462 (3.0%) | 139 / 64620 (0.2%) | −113.5 | −110.9 | 14.10 |
| TP53 SRX19538282 | Osteoblasts Bone | 197 / 6462 (3.0%) | 142 / 64620 (0.2%) | −113.3 | −110.8 | 13.87 |
| CTCF SRX12008351 | MCF 10A Breast | 1294 / 6462 (20.0%) | 6454 / 64620 (10.0%) | −113.1 | −110.6 | 2.00 |
| BRPF3 SRX796086 | RKO Digestive tract | 674 / 6462 (10.4%) | 2319 / 64620 (3.6%) | −112.3 | −109.8 | 2.91 |
| Epitope tags SRX2255894 | 293 Kidney | 652 / 6462 (10.1%) | 2193 / 64620 (3.4%) | −112.3 | −109.8 | 2.97 |
| TP53 SRX19538272 | U2OS Bone | 297 / 6462 (4.6%) | 465 / 64620 (0.7%) | −110.7 | −108.2 | 6.39 |
| BRPF3 SRX796085 | RKO Digestive tract | 516 / 6462 (8.0%) | 1464 / 64620 (2.3%) | −110.5 | −108.0 | 3.52 |
| LARP7 SRX2198835 | HeLa Uterus | 976 / 6462 (15.1%) | 4273 / 64620 (6.6%) | −110.1 | −107.6 | 2.28 |
| Epitope tags SRX2867680 | 293 Kidney | 946 / 6462 (14.6%) | 4080 / 64620 (6.3%) | −109.6 | −107.1 | 2.32 |
| ZFX SRX7805372 | 293 Kidney | 736 / 6462 (11.4%) | 2739 / 64620 (4.2%) | −109.1 | −106.6 | 2.69 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 316 / 6462 (4.9%) | 559 / 64620 (0.9%) | −107.2 | −104.8 | 5.65 |
| CTCF SRX12008350 | MCF 10A Breast | 1302 / 6462 (20.1%) | 6666 / 64620 (10.3%) | −106.7 | −104.2 | 1.95 |
| CHD6 SRX17709201 | C4-2 Prostate | 715 / 6462 (11.1%) | 2659 / 64620 (4.1%) | −106.0 | −103.5 | 2.69 |
| GRHL3 SRX2582162 | NHEK Epidermis | 520 / 6462 (8.0%) | 1560 / 64620 (2.4%) | −103.9 | −101.4 | 3.33 |
| Epitope tags SRX10549778 | K-562 Blood | 530 / 6462 (8.2%) | 1623 / 64620 (2.5%) | −103.2 | −100.7 | 3.27 |
| CHD6 SRX17709200 | C4-2 Prostate | 726 / 6462 (11.2%) | 2793 / 64620 (4.3%) | −101.8 | −99.3 | 2.60 |
| HIF1A SRX20663235 | HK-2 Kidney | 188 / 6462 (2.9%) | 156 / 64620 (0.2%) | −101.6 | −99.1 | 12.05 |
| GATA3 SRX190194 | SK-N-SH Neural | 238 / 6462 (3.7%) | 7328 / 64620 (11.3%) | −101.3 | −98.8 | 0.32 |
| CTCF SRX12008354 | MCF 10A Breast | 1665 / 6462 (25.8%) | 9630 / 64620 (14.9%) | −101.1 | −98.6 | 1.73 |
| MED1 SRX4937338 | HCT 116 Digestive tract | 662 / 6462 (10.2%) | 2418 / 64620 (3.7%) | −100.5 | −98.1 | 2.74 |
| STAT5B SRX831881 | CD8+ T cells Blood | 150 / 6462 (2.3%) | 72 / 64620 (0.1%) | −100.3 | −97.8 | 20.83 |
| MBD3 SRX1674506 | HeLa Uterus | 1131 / 6462 (17.5%) | 5614 / 64620 (8.7%) | −98.3 | −95.9 | 2.01 |
| RBFOX2 SRX3323050 | Hep G2 Liver | 711 / 6462 (11.0%) | 2757 / 64620 (4.3%) | −98.1 | −95.7 | 2.58 |
| NUP98 SRX20440536 | Keratinocytes Epidermis | 265 / 6462 (4.1%) | 423 / 64620 (0.7%) | −97.3 | −94.8 | 6.26 |
| LEO1 SRX1873456 | SEM Blood | 649 / 6462 (10.0%) | 2391 / 64620 (3.7%) | −97.2 | −94.8 | 2.71 |
| GRHL3 SRX2582161 | NHEK Epidermis | 431 / 6462 (6.7%) | 1173 / 64620 (1.8%) | −96.6 | −94.2 | 3.67 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 304 / 6462 (4.7%) | 582 / 64620 (0.9%) | −96.6 | −94.1 | 5.22 |
| MethylCap SRX014767 | NB-4 Blood | 766 / 6462 (11.9%) | 3150 / 64620 (4.9%) | −95.6 | −93.2 | 2.43 |
| SSRP1 SRX3436567 | HT-1080 Bone | 213 / 6462 (3.3%) | 253 / 64620 (0.4%) | −95.2 | −92.8 | 8.42 |
| ESR1 SRX2897220 | Breast cancer cells Breast | 704 / 6462 (10.9%) | 2773 / 64620 (4.3%) | −94.5 | −92.1 | 2.54 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 247 / 6462 (3.8%) | 7235 / 64620 (11.2%) | −94.0 | −91.6 | 0.34 |
| HEXIM1 SRX1177905 | HCT 116 Digestive tract | 807 / 6462 (12.5%) | 3455 / 64620 (5.3%) | −93.6 | −91.2 | 2.34 |
| CDK9 SRX10131663 | Bronchial tracheal epithelial cells Lung | 508 / 6462 (7.9%) | 1619 / 64620 (2.5%) | −93.6 | −91.2 | 3.14 |
| ASCL1 SRX8949802 | Unclassified Unclassified | 783 / 6462 (12.1%) | 3299 / 64620 (5.1%) | −93.5 | −91.1 | 2.37 |
| KLF4 SRX12144701 | T/C28a2 Bone | 1179 / 6462 (18.2%) | 6127 / 64620 (9.5%) | −91.9 | −89.5 | 1.92 |
| KMT2A SRX2281249 | SEM Blood | 841 / 6462 (13.0%) | 3726 / 64620 (5.8%) | −91.5 | −89.1 | 2.26 |
| CDK9 SRX20230567 | Ishikawa Uterus | 775 / 6462 (12.0%) | 3291 / 64620 (5.1%) | −91.2 | −88.8 | 2.35 |
| BMI1 SRX644729 | 293 Kidney | 136 / 6462 (2.1%) | 65 / 64620 (0.1%) | −91.1 | −88.7 | 20.92 |
| Epitope tags SRX10549777 | K-562 Blood | 1047 / 6462 (16.2%) | 5177 / 64620 (8.0%) | −91.0 | −88.6 | 2.02 |
| Epitope tags SRX7276677 | 293 Kidney | 1130 / 6462 (17.5%) | 5786 / 64620 (9.0%) | −90.9 | −88.5 | 1.95 |
| ING5 SRX286202 | RKO Digestive tract | 577 / 6462 (8.9%) | 2055 / 64620 (3.2%) | −90.7 | −88.3 | 2.81 |
| CDK9 SRX20230570 | Ishikawa Uterus | 747 / 6462 (11.6%) | 3117 / 64620 (4.8%) | −90.7 | −88.3 | 2.40 |
| MED1 SRX4937342 | HCT 116 Digestive tract | 610 / 6462 (9.4%) | 2261 / 64620 (3.5%) | −90.2 | −87.9 | 2.70 |
| MEAF6 SRX10606586 | GIST-T1 Digestive tract | 556 / 6462 (8.6%) | 1947 / 64620 (3.0%) | −89.6 | −87.2 | 2.86 |
| FOXL2 SRX6957431 | KGN Gonad | 257 / 6462 (4.0%) | 7231 / 64620 (11.2%) | −89.3 | −86.9 | 0.36 |
| SS18 SRX3468047 | Fibroblasts Others | 282 / 6462 (4.4%) | 7597 / 64620 (11.8%) | −88.9 | −86.5 | 0.37 |
| ATF3 SRX2207918 | CS1AN Epidermis | 970 / 6462 (15.0%) | 4679 / 64620 (7.2%) | −88.7 | −86.3 | 2.07 |
| KMT2A SRX8151120 | VDH-15 Others | 895 / 6462 (13.9%) | 4153 / 64620 (6.4%) | −88.6 | −86.3 | 2.16 |
| SUZ12 SRX10184494 | K-562 Blood | 1058 / 6462 (16.4%) | 5319 / 64620 (8.2%) | −88.5 | −86.1 | 1.99 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 504 / 6462 (7.8%) | 1673 / 64620 (2.6%) | −87.7 | −85.3 | 3.01 |
| MED1 SRX4937336 | HCT 116 Digestive tract | 706 / 6462 (10.9%) | 2910 / 64620 (4.5%) | −87.5 | −85.1 | 2.43 |
| CNOT3 SRX886388 | Colorectal carcinoma Digestive tract | 835 / 6462 (12.9%) | 3769 / 64620 (5.8%) | −87.3 | −85.0 | 2.22 |
| HDAC1 SRX20517420 | Keratinocytes Epidermis | 724 / 6462 (11.2%) | 3031 / 64620 (4.7%) | −87.1 | −84.8 | 2.39 |
| EP300 SRX2671813 | Fibroblasts Others | 70 / 6462 (1.1%) | 3926 / 64620 (6.1%) | −86.6 | −84.3 | 0.18 |
| BCOR SRX10184493 | K-562 Blood | 925 / 6462 (14.3%) | 4415 / 64620 (6.8%) | −86.3 | −84.0 | 2.10 |
| TET2 SRX1427029 | 293 Kidney | 575 / 6462 (8.9%) | 2109 / 64620 (3.3%) | −86.3 | −84.0 | 2.73 |
| MEAF6 DRX234811 | 293 Kidney | 710 / 6462 (11.0%) | 2955 / 64620 (4.6%) | −86.3 | −84.0 | 2.40 |
| FOXA1 SRX4815198 | MCF-7 Breast | 396 / 6462 (6.1%) | 9164 / 64620 (14.2%) | −86.2 | −83.9 | 0.43 |
| FOXA1 SRX176862 | MCF-7 Breast | 140 / 6462 (2.2%) | 5222 / 64620 (8.1%) | −86.2 | −83.8 | 0.27 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 261 / 6462 (4.0%) | 478 / 64620 (0.7%) | −86.0 | −83.7 | 5.46 |
| FOXA1 SRX4815197 | MCF-7 Breast | 280 / 6462 (4.3%) | 7465 / 64620 (11.6%) | −86.0 | −83.6 | 0.38 |
| MED1 SRX4937340 | HCT 116 Digestive tract | 698 / 6462 (10.8%) | 2884 / 64620 (4.5%) | −85.9 | −83.6 | 2.42 |
| KMT2A SRX1293531 | MV-4-11 Blood | 1051 / 6462 (16.3%) | 5335 / 64620 (8.3%) | −85.7 | −83.4 | 1.97 |
| CTCF SRX10976000 | NALM-6 Blood | 1197 / 6462 (18.5%) | 6431 / 64620 (10.0%) | −85.5 | −83.2 | 1.86 |
| CBFB SRX265218 | ME-1 Blood | 648 / 6462 (10.0%) | 2574 / 64620 (4.0%) | −85.4 | −83.1 | 2.52 |
| KAT7 DRX234808 | 293 Kidney | 357 / 6462 (5.5%) | 922 / 64620 (1.4%) | −84.7 | −82.4 | 3.87 |
| RBFOX2 SRX3323051 | Hep G2 Liver | 661 / 6462 (10.2%) | 2678 / 64620 (4.1%) | −84.2 | −81.9 | 2.47 |
| CTCF SRX10976001 | NALM-6 Blood | 1072 / 6462 (16.6%) | 5532 / 64620 (8.6%) | −84.0 | −81.7 | 1.94 |
| KMT2A SRX8151117 | VDH-15 Others | 892 / 6462 (13.8%) | 4237 / 64620 (6.6%) | −83.8 | −81.5 | 2.11 |
| KMT2A SRX8151118 | VDH-15 Others | 855 / 6462 (13.2%) | 3987 / 64620 (6.2%) | −83.5 | −81.2 | 2.14 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 216 / 6462 (3.3%) | 6387 / 64620 (9.9%) | −83.3 | −81.0 | 0.34 |
| KMT2A SRX8151121 | VDH-15 Others | 896 / 6462 (13.9%) | 4293 / 64620 (6.6%) | −82.7 | −80.4 | 2.09 |
| RBM22 SRX4708083 | K-562 Blood | 418 / 6462 (6.5%) | 1259 / 64620 (1.9%) | −82.6 | −80.4 | 3.32 |
| NFYB SRX16608147 | HeLa Uterus | 138 / 6462 (2.1%) | 92 / 64620 (0.1%) | −82.0 | −79.8 | 15.00 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 406 / 6462 (6.3%) | 9141 / 64620 (14.1%) | −82.0 | −79.7 | 0.44 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 77 / 6462 (1.2%) | 3931 / 64620 (6.1%) | −81.7 | −79.4 | 0.20 |
| CTCF SRX10976007 | NALM-6 Blood | 1072 / 6462 (16.6%) | 5594 / 64620 (8.7%) | −81.6 | −79.3 | 1.92 |
| KMT2A SRX8151119 | VDH-15 Others | 808 / 6462 (12.5%) | 3706 / 64620 (5.7%) | −81.5 | −79.2 | 2.18 |
| GATA1 SRX4172744 | HCT 116 Digestive tract | 660 / 6462 (10.2%) | 2724 / 64620 (4.2%) | −81.1 | −78.8 | 2.42 |
| CDK9 SRX20230573 | Ishikawa Uterus | 919 / 6462 (14.2%) | 4495 / 64620 (7.0%) | −81.0 | −78.7 | 2.04 |
| Epitope tags SRX4892334 | 293 Kidney | 979 / 6462 (15.2%) | 4950 / 64620 (7.7%) | −80.1 | −77.8 | 1.98 |
| ASCL1 SRX8949803 | Unclassified Unclassified | 799 / 6462 (12.4%) | 3675 / 64620 (5.7%) | −80.1 | −77.8 | 2.17 |
| YAP1 SRX1038945 | IMR-90 Lung | 68 / 6462 (1.1%) | 3704 / 64620 (5.7%) | −80.1 | −77.8 | 0.18 |
| ATF1 SRX11470446 | Mesenchymal stem cells Others | 298 / 6462 (4.6%) | 7522 / 64620 (11.6%) | −80.0 | −77.7 | 0.40 |
| FOXA1 SRX176863 | MCF-7 Breast | 138 / 6462 (2.1%) | 4987 / 64620 (7.7%) | −79.6 | −77.4 | 0.28 |
| ASCL1 SRX8949797 | Unclassified Unclassified | 857 / 6462 (13.3%) | 4088 / 64620 (6.3%) | −79.6 | −77.3 | 2.10 |
| SP1 SRX113706 | HCT 116 Digestive tract | 779 / 6462 (12.1%) | 3554 / 64620 (5.5%) | −79.3 | −77.0 | 2.19 |
| ERG SRX063918 | MCF-7 Breast | 635 / 6462 (9.8%) | 2600 / 64620 (4.0%) | −79.1 | −76.8 | 2.44 |
| RBFOX2 SRX3322781 | K-562 Blood | 837 / 6462 (13.0%) | 3961 / 64620 (6.1%) | −79.0 | −76.7 | 2.11 |
| JUN SRX17561461 | LPS141 Adipocyte | 161 / 6462 (2.5%) | 5354 / 64620 (8.3%) | −79.0 | −76.7 | 0.30 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 285 / 6462 (4.4%) | 7288 / 64620 (11.3%) | −78.9 | −76.6 | 0.39 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 294 / 6462 (4.5%) | 7420 / 64620 (11.5%) | −78.8 | −76.6 | 0.40 |
| MEAF6 DRX300417 | 293 Kidney | 647 / 6462 (10.0%) | 2685 / 64620 (4.2%) | −78.8 | −76.5 | 2.41 |
| Epitope tags SRX3657345 | 293 Kidney | 974 / 6462 (15.1%) | 4953 / 64620 (7.7%) | −78.5 | −76.3 | 1.97 |
| SNAI2 SRX476921 | Keratinocytes Epidermis | 892 / 6462 (13.8%) | 4366 / 64620 (6.8%) | −78.3 | −76.1 | 2.04 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 413 / 6462 (6.4%) | 9078 / 64620 (14.0%) | −77.8 | −75.6 | 0.45 |
| MethylCap SRX014766 | NB-4 Blood | 665 / 6462 (10.3%) | 2822 / 64620 (4.4%) | −77.5 | −75.3 | 2.36 |
| RELA SRX2207673 | HUVEC Cardiovascular | 453 / 6462 (7.0%) | 9614 / 64620 (14.9%) | −77.5 | −75.3 | 0.47 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 269 / 6462 (4.2%) | 6988 / 64620 (10.8%) | −77.0 | −74.8 | 0.38 |
| FOXL2 SRX6957477 | KGN Gonad | 109 / 6462 (1.7%) | 4390 / 64620 (6.8%) | −76.9 | −74.6 | 0.25 |
| BRD4 SRX8082233 | Keratinocytes Epidermis | 711 / 6462 (11.0%) | 3155 / 64620 (4.9%) | −76.3 | −74.1 | 2.25 |
| MCM3 SRX9107920 | hTERT RPE-1 Neural | 404 / 6462 (6.3%) | 1261 / 64620 (2.0%) | −76.2 | −73.9 | 3.20 |
| TCF12 SRX190356 | SK-N-SH Neural | 339 / 6462 (5.2%) | 7972 / 64620 (12.3%) | −76.1 | −73.8 | 0.43 |
| FOXA2 SRX3644342 | BJ Epidermis | 169 / 6462 (2.6%) | 5394 / 64620 (8.3%) | −76.0 | −73.8 | 0.31 |
| NABP2 SRX9523535 | HT-1080 Bone | 570 / 6462 (8.8%) | 2248 / 64620 (3.5%) | −75.7 | −73.5 | 2.54 |
| DOT1L SRX10606582 | GIST-T1 Digestive tract | 703 / 6462 (10.9%) | 3116 / 64620 (4.8%) | −75.5 | −73.3 | 2.26 |
| FOSL2 SRX5054309 | Neural progenitor cells Neural | 108 / 6462 (1.7%) | 4326 / 64620 (6.7%) | −75.4 | −73.2 | 0.25 |
| MYOCD SRX5598318 | A549 Lung | 704 / 6462 (10.9%) | 3127 / 64620 (4.8%) | −75.3 | −73.1 | 2.25 |
| TET2 SRX2513053 | Jurkat Blood | 868 / 6462 (13.4%) | 4267 / 64620 (6.6%) | −75.2 | −73.0 | 2.03 |
| HDAC1 SRX20517422 | Keratinocytes Epidermis | 583 / 6462 (9.0%) | 2337 / 64620 (3.6%) | −75.2 | −73.0 | 2.49 |
| CDK9 SRX20230572 | Ishikawa Uterus | 712 / 6462 (11.0%) | 3192 / 64620 (4.9%) | −74.8 | −72.6 | 2.23 |
| KLF3 SRX7214021 | Keratinocytes Epidermis | 716 / 6462 (11.1%) | 3224 / 64620 (5.0%) | −74.6 | −72.4 | 2.22 |
| ESR1 SRX2901942 | Ishikawa Uterus | 502 / 6462 (7.8%) | 1850 / 64620 (2.9%) | −74.4 | −72.2 | 2.71 |
| PHF6 SRX11508321 | G-401 Kidney | 639 / 6462 (9.9%) | 2713 / 64620 (4.2%) | −74.3 | −72.1 | 2.36 |
| KLF4 SRX12144702 | T/C28a2 Bone | 1014 / 6462 (15.7%) | 5360 / 64620 (8.3%) | −74.2 | −72.0 | 1.89 |
| TFEB SRX6743819 | iPS cells Pluripotent stem cell | 613 / 6462 (9.5%) | 2549 / 64620 (3.9%) | −74.2 | −72.0 | 2.40 |
| Epitope tags SRX15426925 | Keratinocytes Epidermis | 250 / 6462 (3.9%) | 517 / 64620 (0.8%) | −74.1 | −71.9 | 4.84 |
| Epitope tags SRX11470449 | Mesenchymal stem cells Others | 177 / 6462 (2.7%) | 5448 / 64620 (8.4%) | −73.8 | −71.6 | 0.32 |
| BCORL1 SRX10184497 | K-562 Blood | 836 / 6462 (12.9%) | 4074 / 64620 (6.3%) | −73.7 | −71.6 | 2.05 |
| INTS12 SRX1711343 | Bronchial epithelial cells Lung | 584 / 6462 (9.0%) | 2372 / 64620 (3.7%) | −73.6 | −71.4 | 2.46 |
| SNAI2 SRX476922 | Keratinocytes Epidermis | 910 / 6462 (14.1%) | 4614 / 64620 (7.1%) | −73.5 | −71.3 | 1.97 |
| BCORL1 SRX10184496 | K-562 Blood | 825 / 6462 (12.8%) | 4003 / 64620 (6.2%) | −73.4 | −71.3 | 2.06 |
| GATA2 SRX3503584 | Endometrial stromal cells Uterus | 127 / 6462 (2.0%) | 4595 / 64620 (7.1%) | −73.3 | −71.1 | 0.28 |
| TAL1 SRX393518 | Primary endothelial cells Cardiovascular | 166 / 6462 (2.6%) | 5246 / 64620 (8.1%) | −73.1 | −70.9 | 0.32 |
| DDX21 SRX8257415 | A-375 Epidermis | 394 / 6462 (6.1%) | 1245 / 64620 (1.9%) | −73.0 | −70.9 | 3.16 |
| Epitope tags SRX11470445 | Mesenchymal stem cells Others | 151 / 6462 (2.3%) | 4987 / 64620 (7.7%) | −72.8 | −70.6 | 0.30 |
| YAP1 SRX5718140 | 293 Kidney | 211 / 6462 (3.3%) | 5940 / 64620 (9.2%) | −72.5 | −70.3 | 0.36 |
| CTCF SRX10976002 | NALM-6 Blood | 1162 / 6462 (18.0%) | 6536 / 64620 (10.1%) | −72.3 | −70.2 | 1.78 |
| CDK9 SRX20230574 | Ishikawa Uterus | 619 / 6462 (9.6%) | 2629 / 64620 (4.1%) | −71.9 | −69.7 | 2.35 |
| BMI1 SRX8726297 | Tumor Others | 641 / 6462 (9.9%) | 2773 / 64620 (4.3%) | −71.9 | −69.7 | 2.31 |
| SOX2 SRX2731713 | Lung cancer cell line Lung | 108 / 6462 (1.7%) | 53 / 64620 (0.1%) | −71.8 | −69.7 | 20.38 |
| NR3C1 SRX2609664 | HASM2 Lung | 173 / 6462 (2.7%) | 5314 / 64620 (8.2%) | −71.7 | −69.6 | 0.33 |
| TAF1 SRX11120885 | MCF-7 Breast | 699 / 6462 (10.8%) | 3167 / 64620 (4.9%) | −71.7 | −69.5 | 2.21 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 289 / 6462 (4.5%) | 7081 / 64620 (11.0%) | −71.6 | −69.4 | 0.41 |
| BCORL1 SRX10184498 | K-562 Blood | 846 / 6462 (13.1%) | 4210 / 64620 (6.5%) | −71.0 | −68.9 | 2.01 |
| ZFX SRX7805370 | 293 Kidney | 486 / 6462 (7.5%) | 1805 / 64620 (2.8%) | −71.0 | −68.9 | 2.69 |
| DOT1L SRX10606583 | GIST-T1 Digestive tract | 508 / 6462 (7.9%) | 1942 / 64620 (3.0%) | −70.8 | −68.7 | 2.62 |
| KLF3 SRX7214022 | Keratinocytes Epidermis | 728 / 6462 (11.3%) | 3387 / 64620 (5.2%) | −70.7 | −68.6 | 2.15 |
| KMT2A SRX8151116 | VDH-15 Others | 690 / 6462 (10.7%) | 3128 / 64620 (4.8%) | −70.7 | −68.5 | 2.21 |
| RELA SRX2207672 | HUVEC Cardiovascular | 511 / 6462 (7.9%) | 10104 / 64620 (15.6%) | −70.6 | −68.5 | 0.51 |
| DNA-RNA hybrid SRX14756935 | MDA-MB-436 Breast | 255 / 6462 (3.9%) | 567 / 64620 (0.9%) | −70.6 | −68.4 | 4.50 |
| WAS SRX5371250 | GM11518 Blood | 469 / 6462 (7.3%) | 1711 / 64620 (2.6%) | −70.4 | −68.3 | 2.74 |
| KAT7 DRX300414 | 293 Kidney | 274 / 6462 (4.2%) | 656 / 64620 (1.0%) | −70.4 | −68.3 | 4.18 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 220 / 6462 (3.4%) | 418 / 64620 (0.6%) | −70.3 | −68.1 | 5.26 |
| RBFOX2 SRX3322782 | K-562 Blood | 770 / 6462 (11.9%) | 3690 / 64620 (5.7%) | −70.3 | −68.1 | 2.09 |
| TET1 SRX10382426 | hESC H1 Pluripotent stem cell | 970 / 6462 (15.0%) | 5139 / 64620 (8.0%) | −70.2 | −68.0 | 1.89 |
| Epitope tags SRX4192708 | MDA-MB-231 Breast | 437 / 6462 (6.8%) | 1528 / 64620 (2.4%) | −70.1 | −68.0 | 2.86 |
| G3BP1 SRX24196609 | KGN Gonad | 660 / 6462 (10.2%) | 2943 / 64620 (4.6%) | −69.7 | −67.6 | 2.24 |
| NR3C1 SRX2609665 | HASM2 Lung | 137 / 6462 (2.1%) | 4652 / 64620 (7.2%) | −69.7 | −67.6 | 0.29 |
| DNMT3B SRX2862487 | hESC HUES8 Pluripotent stem cell | 142 / 6462 (2.2%) | 144 / 64620 (0.2%) | −69.5 | −67.4 | 9.86 |
| FOXA1 SRX3931044 | MCF-7 Breast | 283 / 6462 (4.4%) | 6912 / 64620 (10.7%) | −69.3 | −67.2 | 0.41 |
| CEBPB SRX150598 | IMR-90 Lung | 259 / 6462 (4.0%) | 6548 / 64620 (10.1%) | −69.0 | −66.9 | 0.40 |
| ASCL1 SRX11245139 | DMS 53 Lung | 605 / 6462 (9.4%) | 2595 / 64620 (4.0%) | −68.8 | −66.7 | 2.33 |
| Epitope tags DRX443510 | 293 Kidney | 582 / 6462 (9.0%) | 2447 / 64620 (3.8%) | −68.8 | −66.6 | 2.38 |
| Epitope tags SRX11470532 | Mesenchymal stem cells Others | 159 / 6462 (2.5%) | 4979 / 64620 (7.7%) | −68.5 | −66.4 | 0.32 |
| Epitope tags SRX2255895 | 293 Kidney | 404 / 6462 (6.3%) | 1361 / 64620 (2.1%) | −68.4 | −66.3 | 2.97 |
| KAT6A SRX20971022 | Fibroblasts Others | 106 / 6462 (1.6%) | 57 / 64620 (0.1%) | −68.4 | −66.3 | 18.60 |
| JUN SRX6582172 | Fibroblasts Others | 164 / 6462 (2.5%) | 5042 / 64620 (7.8%) | −67.9 | −65.8 | 0.33 |
| CDT1 SRX10644243 | HCT 116 Digestive tract | 651 / 6462 (10.1%) | 2923 / 64620 (4.5%) | −67.8 | −65.7 | 2.23 |
| FOXA1 SRX1161173 | MCF-7 Breast | 100 / 6462 (1.5%) | 3943 / 64620 (6.1%) | −67.6 | −65.5 | 0.25 |
| PBX3 SRX190343 | SK-N-SH Neural | 276 / 6462 (4.3%) | 6742 / 64620 (10.4%) | −67.6 | −65.5 | 0.41 |
| TFAP2A SRX20744801 | GP5d Digestive tract | 413 / 6462 (6.4%) | 1425 / 64620 (2.2%) | −67.4 | −65.3 | 2.90 |
| NR3C1 SRX2609666 | HASM2 Lung | 121 / 6462 (1.9%) | 4301 / 64620 (6.7%) | −67.2 | −65.1 | 0.28 |
| Epitope tags SRX20570808 | Keratinocytes Epidermis | 371 / 6462 (5.7%) | 1192 / 64620 (1.8%) | −67.2 | −65.0 | 3.11 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 277 / 6462 (4.3%) | 6739 / 64620 (10.4%) | −67.1 | −65.0 | 0.41 |
| FOXA1 SRX1161177 | MCF-7 Breast | 131 / 6462 (2.0%) | 4466 / 64620 (6.9%) | −67.0 | −64.9 | 0.29 |
| MED1 SRX8707939 | Keratinocytes Epidermis | 336 / 6462 (5.2%) | 1004 / 64620 (1.6%) | −66.9 | −64.8 | 3.35 |
| SMARCA2 SRX8119677 | MeT-5A Others | 211 / 6462 (3.3%) | 5732 / 64620 (8.9%) | −66.5 | −64.4 | 0.37 |
| NR3C1 SRX2609662 | HASM2 Lung | 154 / 6462 (2.4%) | 4831 / 64620 (7.5%) | −66.5 | −64.4 | 0.32 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 379 / 6462 (5.9%) | 8156 / 64620 (12.6%) | −66.4 | −64.3 | 0.46 |
| TBP SRX4367431 | Bronchial tracheal epithelial cells Lung | 539 / 6462 (8.3%) | 2214 / 64620 (3.4%) | −66.3 | −64.2 | 2.43 |
| JUN SRX6582171 | GM07492 Others | 255 / 6462 (3.9%) | 6386 / 64620 (9.9%) | −66.3 | −64.2 | 0.40 |
| FOXA1 SRX1161175 | MCF-7 Breast | 93 / 6462 (1.4%) | 3776 / 64620 (5.8%) | −66.2 | −64.1 | 0.25 |
| JUND SRX190357 | SK-N-SH Neural | 163 / 6462 (2.5%) | 4962 / 64620 (7.7%) | −66.1 | −64.0 | 0.33 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 424 / 6462 (6.6%) | 8756 / 64620 (13.5%) | −66.1 | −64.0 | 0.48 |
| ETS1 SRX3033231 | HEYA8 Gonad | 140 / 6462 (2.2%) | 152 / 64620 (0.2%) | −66.1 | −64.0 | 9.21 |
| SSRP1 SRX3436566 | HT-1080 Bone | 147 / 6462 (2.3%) | 174 / 64620 (0.3%) | −66.0 | −63.9 | 8.45 |
| EP300 SRX2671792 | Cardiac progenitor cells Cardiovascular | 86 / 6462 (1.3%) | 3641 / 64620 (5.6%) | −66.0 | −63.9 | 0.24 |
| TEAD1 SRX14688734 | HUVEC Cardiovascular | 102 / 6462 (1.6%) | 3920 / 64620 (6.1%) | −65.7 | −63.6 | 0.26 |
| Epitope tags SRX15426922 | Keratinocytes Epidermis | 306 / 6462 (4.7%) | 861 / 64620 (1.3%) | −65.6 | −63.6 | 3.55 |
| Epitope tags SRX4192709 | MDA-MB-231 Breast | 245 / 6462 (3.8%) | 563 / 64620 (0.9%) | −65.6 | −63.6 | 4.35 |
| JUNB SRX8488073 | SUM 229PE Breast | 253 / 6462 (3.9%) | 6326 / 64620 (9.8%) | −65.5 | −63.4 | 0.40 |
| ATF1 SRX11470450 | Mesenchymal stem cells Others | 255 / 6462 (3.9%) | 6344 / 64620 (9.8%) | −65.1 | −63.1 | 0.40 |
| CXXC1 SRX1424886 | SEM Blood | 584 / 6462 (9.0%) | 2534 / 64620 (3.9%) | −64.9 | −62.9 | 2.30 |
| WAS SRX5371248 | Lymphoblastoid cell line Blood | 387 / 6462 (6.0%) | 1315 / 64620 (2.0%) | −64.6 | −62.6 | 2.94 |
| EP300 SRX100540 | SK-N-SH Neural | 187 / 6462 (2.9%) | 5294 / 64620 (8.2%) | −64.6 | −62.6 | 0.35 |
| KAT6A DRX366109 | 293 Kidney | 813 / 6462 (12.6%) | 4139 / 64620 (6.4%) | −64.3 | −62.2 | 1.96 |
| SMARCA4 SRX5212362 | Mel270 Others | 225 / 6462 (3.5%) | 5860 / 64620 (9.1%) | −64.2 | −62.1 | 0.38 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 88 / 6462 (1.4%) | 3620 / 64620 (5.6%) | −64.2 | −62.1 | 0.24 |
| ING2 SRX286201 | RKO Digestive tract | 565 / 6462 (8.7%) | 2424 / 64620 (3.8%) | −64.1 | −62.1 | 2.33 |
| Epitope tags SRX15725650 | 293 Kidney | 650 / 6462 (10.1%) | 2995 / 64620 (4.6%) | −64.1 | −62.1 | 2.17 |
| BRD4 SRX8082232 | Keratinocytes Epidermis | 419 / 6462 (6.5%) | 1512 / 64620 (2.3%) | −63.9 | −61.9 | 2.77 |
| PRRX1 SRX15235713 | Hs 578T Breast | 158 / 6462 (2.4%) | 4808 / 64620 (7.4%) | −63.9 | −61.8 | 0.33 |
| JADE3 DRX300415 | 293 Kidney | 599 / 6462 (9.3%) | 2655 / 64620 (4.1%) | −63.9 | −61.8 | 2.26 |
| FOS SRX150477 | MCF 10A Breast | 335 / 6462 (5.2%) | 7440 / 64620 (11.5%) | −63.8 | −61.8 | 0.45 |
| BRD4 SRX1224602 | MCF 10A Breast | 344 / 6462 (5.3%) | 1085 / 64620 (1.7%) | −63.8 | −61.8 | 3.17 |
| MED1 SRX8391104 | Head and neck squamous cell carcinoma Others | 226 / 6462 (3.5%) | 494 / 64620 (0.8%) | −63.6 | −61.6 | 4.57 |
| Epitope tags SRX15725652 | 293 Kidney | 721 / 6462 (11.2%) | 3502 / 64620 (5.4%) | −63.5 | −61.4 | 2.06 |
| NR3C1 SRX2609659 | HASM2 Lung | 151 / 6462 (2.3%) | 4680 / 64620 (7.2%) | −63.4 | −61.4 | 0.32 |
| FOXA1 SRX3923514 | MCF-7 Breast | 131 / 6462 (2.0%) | 4349 / 64620 (6.7%) | −63.4 | −61.4 | 0.30 |
| RTF1 SRX15147196 | DLD-1 Digestive tract | 286 / 6462 (4.4%) | 784 / 64620 (1.2%) | −63.3 | −61.2 | 3.65 |
| BRD4 SRX23813262 | C4-2B Prostate | 608 / 6462 (9.4%) | 2728 / 64620 (4.2%) | −63.2 | −61.2 | 2.23 |
| FOSL2 SRX5054308 | Neural progenitor cells Neural | 88 / 6462 (1.4%) | 3588 / 64620 (5.6%) | −63.1 | −61.1 | 0.25 |
| SMARCA4 SRX5075175 | Neural progenitor cells Neural | 200 / 6462 (3.1%) | 5442 / 64620 (8.4%) | −63.1 | −61.0 | 0.37 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 99 / 6462 (1.5%) | 3785 / 64620 (5.9%) | −63.0 | −61.0 | 0.26 |
| FOXL2 SRX6957481 | KGN Gonad | 78 / 6462 (1.2%) | 3400 / 64620 (5.3%) | −62.9 | −60.9 | 0.23 |
| GATA3 SRX176864 | MCF-7 Breast | 94 / 6462 (1.5%) | 3687 / 64620 (5.7%) | −62.7 | −60.7 | 0.25 |
| CTCF SRX10976008 | NALM-6 Blood | 980 / 6462 (15.2%) | 5433 / 64620 (8.4%) | −62.5 | −60.5 | 1.80 |
| FOXA1 SRX219284 | LNCAP Prostate | 178 / 6462 (2.8%) | 5067 / 64620 (7.8%) | −62.2 | −60.1 | 0.35 |
| BAHCC1 SRX8449942 | Jurkat Blood | 985 / 6462 (15.2%) | 5487 / 64620 (8.5%) | −62.0 | −59.9 | 1.80 |
| HDAC1 SRX17989501 | PBMC Blood | 803 / 6462 (12.4%) | 4133 / 64620 (6.4%) | −61.7 | −59.7 | 1.94 |
| GATA3 SRX5057632 | MCF-7 Breast | 85 / 6462 (1.3%) | 3490 / 64620 (5.4%) | −61.7 | −59.6 | 0.24 |
| GTF3C1 SRX4636577 | 293 Kidney | 520 / 6462 (8.0%) | 2178 / 64620 (3.4%) | −61.7 | −59.6 | 2.39 |
| FOXL2 SRX5342375 | SVOG-3e Gonad | 98 / 6462 (1.5%) | 3723 / 64620 (5.8%) | −61.6 | −59.6 | 0.26 |
| RELA SRX7055007 | HAEC Cardiovascular | 247 / 6462 (3.8%) | 6096 / 64620 (9.4%) | −61.6 | −59.6 | 0.41 |
| CTCF SRX10976009 | 697 Blood | 897 / 6462 (13.9%) | 4835 / 64620 (7.5%) | −61.4 | −59.4 | 1.86 |
| Epitope tags SRX14024875 | Mesenchymal stem cells Others | 704 / 6462 (10.9%) | 3429 / 64620 (5.3%) | −61.4 | −59.4 | 2.05 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 104 / 6462 (1.6%) | 3820 / 64620 (5.9%) | −61.3 | −59.3 | 0.27 |
| KDM4C SRX424010 | KYSE-150 Digestive tract | 498 / 6462 (7.7%) | 2045 / 64620 (3.2%) | −61.2 | −59.1 | 2.44 |
| MethylCap SRX026646 | Acute myeloid leukemia Blood | 275 / 6462 (4.3%) | 751 / 64620 (1.2%) | −61.1 | −59.1 | 3.66 |
| KAT6B DRX411443 | 293 Kidney | 827 / 6462 (12.8%) | 4327 / 64620 (6.7%) | −61.1 | −59.1 | 1.91 |
| LEO1 SRX15147190 | DLD-1 Digestive tract | 353 / 6462 (5.5%) | 1170 / 64620 (1.8%) | −61.0 | −59.0 | 3.02 |
| KAT6A DRX366108 | 293 Kidney | 674 / 6462 (10.4%) | 3230 / 64620 (5.0%) | −61.0 | −59.0 | 2.09 |
| JUNB SRX8488074 | SUM 229PE Breast | 183 / 6462 (2.8%) | 5098 / 64620 (7.9%) | −60.8 | −58.8 | 0.36 |
| FOS SRX150478 | MCF 10A Breast | 355 / 6462 (5.5%) | 7591 / 64620 (11.7%) | −60.6 | −58.6 | 0.47 |
| YAP1 SRX1038944 | IMR-90 Lung | 42 / 6462 (0.6%) | 2614 / 64620 (4.0%) | −60.5 | −58.5 | 0.16 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 137 / 6462 (2.1%) | 4350 / 64620 (6.7%) | −60.4 | −58.4 | 0.31 |
| SUPT6H SRX15147167 | DLD-1 Digestive tract | 518 / 6462 (8.0%) | 2189 / 64620 (3.4%) | −60.4 | −58.4 | 2.37 |
| CHD6 SRX17709202 | C4-2 Prostate | 440 / 6462 (6.8%) | 1699 / 64620 (2.6%) | −60.0 | −58.0 | 2.59 |
| FOXA1 SRX371483 | MCF-7 Breast | 164 / 6462 (2.5%) | 4771 / 64620 (7.4%) | −60.0 | −58.0 | 0.34 |
| FOXA1 SRX1161176 | MCF-7 Breast | 137 / 6462 (2.1%) | 4338 / 64620 (6.7%) | −60.0 | −58.0 | 0.32 |
| NELFA SRX10333914 | DLD-1 Digestive tract | 518 / 6462 (8.0%) | 2198 / 64620 (3.4%) | −59.9 | −57.9 | 2.36 |
| TAL1 SRX393516 | Primary endothelial cells Cardiovascular | 161 / 6462 (2.5%) | 4720 / 64620 (7.3%) | −59.9 | −57.9 | 0.34 |
| NR1D1 SRX23813275 | C4-2B Prostate | 672 / 6462 (10.4%) | 3252 / 64620 (5.0%) | −59.4 | −57.4 | 2.07 |
| FOXA1 SRX1885181 | LNCAP Prostate | 122 / 6462 (1.9%) | 4065 / 64620 (6.3%) | −59.4 | −57.4 | 0.30 |
| TEAD1 SRX716558 | SF268 Neural | 62 / 6462 (1.0%) | 2986 / 64620 (4.6%) | −59.4 | −57.4 | 0.21 |
| RUNX1 SRX2963102 | PBMC Blood | 750 / 6462 (11.6%) | 3809 / 64620 (5.9%) | −59.3 | −57.3 | 1.97 |
| CDK9 SRX10131662 | Bronchial tracheal epithelial cells Lung | 252 / 6462 (3.9%) | 655 / 64620 (1.0%) | −59.3 | −57.3 | 3.85 |
| CDK9 SRX20230568 | Ishikawa Uterus | 893 / 6462 (13.8%) | 4870 / 64620 (7.5%) | −59.2 | −57.2 | 1.83 |
| ESR1 SRX2578880 | MDA-MB-231 Breast | 555 / 6462 (8.6%) | 2456 / 64620 (3.8%) | −59.2 | −57.2 | 2.26 |
| HDAC1 SRX17989500 | PBMC Blood | 617 / 6462 (9.5%) | 2879 / 64620 (4.5%) | −58.9 | −57.0 | 2.14 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 182 / 6462 (2.8%) | 5018 / 64620 (7.8%) | −58.9 | −57.0 | 0.36 |
| ZNF711 SRX7805363 | 293 Kidney | 598 / 6462 (9.3%) | 2752 / 64620 (4.3%) | −58.9 | −56.9 | 2.17 |
| FLI1 SRX9738674 | A-673 Bone | 138 / 6462 (2.1%) | 4315 / 64620 (6.7%) | −58.9 | −56.9 | 0.32 |
| FOXA1 SRX028634 | MCF-7 Breast | 61 / 6462 (0.9%) | 2954 / 64620 (4.6%) | −58.8 | −56.8 | 0.21 |
| CREBBP SRX359409 | 293 Kidney | 616 / 6462 (9.5%) | 2877 / 64620 (4.5%) | −58.8 | −56.8 | 2.14 |
| JUN SRX6582163 | BJ-5ta Epidermis | 177 / 6462 (2.7%) | 4916 / 64620 (7.6%) | −58.3 | −56.3 | 0.36 |
| ERG SRX063920 | K-562 Blood | 352 / 6462 (5.4%) | 1203 / 64620 (1.9%) | −58.3 | −56.3 | 2.93 |
| ZFX SRX7805365 | 22Rv1 Prostate | 530 / 6462 (8.2%) | 2309 / 64620 (3.6%) | −58.2 | −56.2 | 2.30 |
| ESR1 SRX371478 | MCF-7 Breast | 192 / 6462 (3.0%) | 5146 / 64620 (8.0%) | −58.2 | −56.2 | 0.37 |
| CTCF SRX10976010 | 697 Blood | 761 / 6462 (11.8%) | 3923 / 64620 (6.1%) | −58.0 | −56.0 | 1.94 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 130 / 6462 (2.0%) | 4148 / 64620 (6.4%) | −57.9 | −55.9 | 0.31 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 182 / 6462 (2.8%) | 4979 / 64620 (7.7%) | −57.9 | −55.9 | 0.37 |
| ASCL1 SRX11245136 | DMS 53 Lung | 670 / 6462 (10.4%) | 3273 / 64620 (5.1%) | −57.9 | −55.9 | 2.05 |
| FOSL2 SRX190296 | SK-N-SH Neural | 191 / 6462 (3.0%) | 5117 / 64620 (7.9%) | −57.8 | −55.8 | 0.37 |
| SMARCA4 SRX5212366 | Mel270 Others | 188 / 6462 (2.9%) | 5068 / 64620 (7.8%) | −57.8 | −55.8 | 0.37 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 130 / 6462 (2.0%) | 4144 / 64620 (6.4%) | −57.8 | −55.8 | 0.31 |
| SMARCA4 SRX5212371 | Mel270 Others | 194 / 6462 (3.0%) | 5158 / 64620 (8.0%) | −57.7 | −55.7 | 0.38 |
| TAF1 SRX11120886 | MCF-7 Breast | 711 / 6462 (11.0%) | 3572 / 64620 (5.5%) | −57.7 | −55.7 | 1.99 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 278 / 6462 (4.3%) | 6394 / 64620 (9.9%) | −57.7 | −55.7 | 0.43 |
| TLE3 SRX4815191 | MCF-7 Breast | 139 / 6462 (2.2%) | 4288 / 64620 (6.6%) | −57.6 | −55.7 | 0.32 |
| FOXA2 SRX100448 | Hep G2 Liver | 155 / 6462 (2.4%) | 4544 / 64620 (7.0%) | −57.6 | −55.6 | 0.34 |
| MEN1 SRX11712604 | K-562 Blood | 550 / 6462 (8.5%) | 2459 / 64620 (3.8%) | −57.4 | −55.5 | 2.24 |
| MAU2 SRX15710550 | Fibroblasts Others | 238 / 6462 (3.7%) | 5807 / 64620 (9.0%) | −57.4 | −55.5 | 0.41 |
| ARID1A SRX5679787 | 12Z Others | 48 / 6462 (0.7%) | 2653 / 64620 (4.1%) | −57.4 | −55.4 | 0.18 |
| FOXA1 SRX371480 | MCF-7 Breast | 95 / 6462 (1.5%) | 3531 / 64620 (5.5%) | −57.2 | −55.3 | 0.27 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 145 / 6462 (2.2%) | 4369 / 64620 (6.8%) | −57.1 | −55.2 | 0.33 |
| TRIM24 SRX1041842 | LNCAP Prostate | 445 / 6462 (6.9%) | 1782 / 64620 (2.8%) | −57.1 | −55.2 | 2.50 |
| FOXA1 SRX1885184 | LNCAP Prostate | 129 / 6462 (2.0%) | 4107 / 64620 (6.4%) | −57.1 | −55.1 | 0.31 |
| FOXA1 SRX219285 | LNCAP Prostate | 130 / 6462 (2.0%) | 4117 / 64620 (6.4%) | −56.9 | −55.0 | 0.32 |
| KAT6B DRX411444 | 293 Kidney | 805 / 6462 (12.5%) | 4275 / 64620 (6.6%) | −56.9 | −55.0 | 1.88 |
| Epitope tags SRX667413 | MCF-7 Breast | 737 / 6462 (11.4%) | 3781 / 64620 (5.9%) | −56.9 | −54.9 | 1.95 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 100 / 6462 (1.5%) | 3607 / 64620 (5.6%) | −56.9 | −54.9 | 0.28 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 320 / 6462 (5.0%) | 6951 / 64620 (10.8%) | −56.8 | −54.9 | 0.46 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 193 / 6462 (3.0%) | 5104 / 64620 (7.9%) | −56.7 | −54.7 | 0.38 |
| FOXA1 SRX371482 | MCF-7 Breast | 218 / 6462 (3.4%) | 5478 / 64620 (8.5%) | −56.6 | −54.7 | 0.40 |
| FOXA1 SRX11222437 | MCF-7 Breast | 97 / 6462 (1.5%) | 3545 / 64620 (5.5%) | −56.6 | −54.6 | 0.27 |
| GFP SRX20436833 | DLD-1 Digestive tract | 571 / 6462 (8.8%) | 2618 / 64620 (4.1%) | −56.5 | −54.6 | 2.18 |
| FOS SRX4192880 | MCF 10A Breast | 255 / 6462 (3.9%) | 6015 / 64620 (9.3%) | −56.5 | −54.6 | 0.42 |
| FOXO1 SRX1048948 | Endometrial stromal cells Uterus | 65 / 6462 (1.0%) | 2960 / 64620 (4.6%) | −56.5 | −54.5 | 0.22 |
| NR3C1 SRX2609661 | HASM2 Lung | 158 / 6462 (2.4%) | 4551 / 64620 (7.0%) | −56.4 | −54.4 | 0.35 |
| JUN SRX150358 | HUVEC Cardiovascular | 84 / 6462 (1.3%) | 3311 / 64620 (5.1%) | −56.4 | −54.4 | 0.25 |
| FOXA1 SRX100506 | Hep G2 Liver | 187 / 6462 (2.9%) | 5000 / 64620 (7.7%) | −56.3 | −54.4 | 0.37 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 238 / 6462 (3.7%) | 5759 / 64620 (8.9%) | −56.2 | −54.2 | 0.41 |
| STAT1 SRX23678708 | K-562 Blood | 586 / 6462 (9.1%) | 2730 / 64620 (4.2%) | −56.1 | −54.2 | 2.15 |
| PAF1 SRX15147186 | DLD-1 Digestive tract | 320 / 6462 (5.0%) | 1051 / 64620 (1.6%) | −56.1 | −54.1 | 3.04 |
| ERG SRX063917 | MCF-7 Breast | 558 / 6462 (8.6%) | 2540 / 64620 (3.9%) | −56.0 | −54.1 | 2.20 |
| Epitope tags SRX22482468 | 293 Kidney | 515 / 6462 (8.0%) | 2253 / 64620 (3.5%) | −56.0 | −54.0 | 2.29 |
| FOXA1 SRX1885182 | LNCAP Prostate | 119 / 6462 (1.8%) | 3901 / 64620 (6.0%) | −55.9 | −54.0 | 0.31 |
| ESR1 SRX371476 | MCF-7 Breast | 112 / 6462 (1.7%) | 3781 / 64620 (5.9%) | −55.8 | −53.9 | 0.30 |
| FOXA1 SRX3931043 | MCF-7 Breast | 148 / 6462 (2.3%) | 4362 / 64620 (6.8%) | −55.6 | −53.7 | 0.34 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 217 / 6462 (3.4%) | 5426 / 64620 (8.4%) | −55.6 | −53.7 | 0.40 |
| FOXA1 SRX3923517 | MCF-7 Breast | 100 / 6462 (1.5%) | 3564 / 64620 (5.5%) | −55.6 | −53.6 | 0.28 |
| CSTF2 SRX10722980 | U2OS Bone | 306 / 6462 (4.7%) | 980 / 64620 (1.5%) | −55.6 | −53.6 | 3.12 |
| Epitope tags SRX9005596 | TM5 Others | 1541 / 6462 (23.8%) | 10228 / 64620 (15.8%) | −55.5 | −53.6 | 1.51 |
| Epitope tags SRX11470534 | Mesenchymal stem cells Others | 267 / 6462 (4.1%) | 6151 / 64620 (9.5%) | −55.5 | −53.6 | 0.43 |
| INTS3 SRX3640569 | HeLa Uterus | 490 / 6462 (7.6%) | 2101 / 64620 (3.3%) | −55.4 | −53.5 | 2.33 |
| FOXA1 SRX5323843 | MCF-7 Breast | 68 / 6462 (1.1%) | 2987 / 64620 (4.6%) | −55.4 | −53.5 | 0.23 |
| FOXA1 SRX2017929 | LNCAP Prostate | 193 / 6462 (3.0%) | 5044 / 64620 (7.8%) | −55.1 | −53.2 | 0.38 |
| FOXA1 SRX1885187 | LNCAP Prostate | 83 / 6462 (1.3%) | 3248 / 64620 (5.0%) | −55.0 | −53.0 | 0.26 |
| HNRNPC SRX4708020 | Hep G2 Liver | 406 / 6462 (6.3%) | 1573 / 64620 (2.4%) | −54.9 | −53.0 | 2.58 |
| SS18L1 SRX10881821 | G-401 Kidney | 753 / 6462 (11.7%) | 3950 / 64620 (6.1%) | −54.9 | −53.0 | 1.91 |
| ZNF711 SRX7805362 | 293 Kidney | 563 / 6462 (8.7%) | 2599 / 64620 (4.0%) | −54.9 | −53.0 | 2.17 |
| FOXA1 SRX11222438 | MCF-7 Breast | 70 / 6462 (1.1%) | 3004 / 64620 (4.6%) | −54.8 | −52.9 | 0.23 |
| FOS SRX070879 | HUVEC Cardiovascular | 153 / 6462 (2.4%) | 4414 / 64620 (6.8%) | −54.8 | −52.9 | 0.35 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 138 / 6462 (2.1%) | 4176 / 64620 (6.5%) | −54.7 | −52.8 | 0.33 |
| FOXA2 SRX3644356 | BJ Epidermis | 126 / 6462 (1.9%) | 3977 / 64620 (6.2%) | −54.6 | −52.7 | 0.32 |
| FOXA1 SRX1166395 | LNCAP Prostate | 68 / 6462 (1.1%) | 2959 / 64620 (4.6%) | −54.5 | −52.6 | 0.23 |
| ESR1 SRX20282961 | MCF-7 Breast | 199 / 6462 (3.1%) | 5118 / 64620 (7.9%) | −54.5 | −52.6 | 0.39 |
| GTF3C1 SRX4636578 | 293 Kidney | 500 / 6462 (7.7%) | 2185 / 64620 (3.4%) | −54.5 | −52.5 | 2.29 |
| LARP7 SRX1177904 | HCT 116 Digestive tract | 435 / 6462 (6.7%) | 1766 / 64620 (2.7%) | −54.4 | −52.5 | 2.46 |
| FOXA1 SRX1885188 | LNCAP Prostate | 108 / 6462 (1.7%) | 3664 / 64620 (5.7%) | −54.4 | −52.5 | 0.29 |
| GATA3 SRX190239 | MCF-7 Breast | 226 / 6462 (3.5%) | 5513 / 64620 (8.5%) | −54.4 | −52.5 | 0.41 |
| SMARCA4 SRX5212357 | Mel270 Others | 205 / 6462 (3.2%) | 5201 / 64620 (8.0%) | −54.4 | −52.5 | 0.39 |
| STAT5A SRX9681372 | ARP-1 Blood | 530 / 6462 (8.2%) | 2389 / 64620 (3.7%) | −54.4 | −52.5 | 2.22 |
| CRTC2 SRX5576990 | A549 Lung | 705 / 6462 (10.9%) | 3614 / 64620 (5.6%) | −54.3 | −52.4 | 1.95 |
| TET2 SRX2513052 | Jurkat Blood | 549 / 6462 (8.5%) | 2518 / 64620 (3.9%) | −54.3 | −52.4 | 2.18 |
| CEBPA SRX2630241 | Hep G2 Liver | 181 / 6462 (2.8%) | 4827 / 64620 (7.5%) | −54.1 | −52.2 | 0.37 |
| PHF6 SRX11508322 | G-401 Kidney | 345 / 6462 (5.3%) | 1223 / 64620 (1.9%) | −54.0 | −52.1 | 2.82 |
| CEBPB SRX11379527 | Liposarcoma, Myxoid Adipocyte | 263 / 6462 (4.1%) | 6036 / 64620 (9.3%) | −54.0 | −52.1 | 0.44 |
| CHD7 SRX3581511 | iPSC derived neural cells Pluripotent stem cell | 38 / 6462 (0.6%) | 2344 / 64620 (3.6%) | −54.0 | −52.1 | 0.16 |
| DNA-RNA hybrid SRX15232261 | MDA-MB-436 Breast | 128 / 6462 (2.0%) | 168 / 64620 (0.3%) | −54.0 | −52.1 | 7.62 |
| NCAPH2 SRX2731517 | 293 Kidney | 499 / 6462 (7.7%) | 2190 / 64620 (3.4%) | −53.9 | −52.0 | 2.28 |
| FOXA1 SRX1787655 | MCF-7 Breast | 69 / 6462 (1.1%) | 2956 / 64620 (4.6%) | −53.9 | −52.0 | 0.23 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 152 / 6462 (2.4%) | 4368 / 64620 (6.8%) | −53.8 | −51.9 | 0.35 |
| FOXA1 SRX3931054 | MCF-7 Breast | 140 / 6462 (2.2%) | 4173 / 64620 (6.5%) | −53.8 | −51.9 | 0.34 |
| SMARCC1 SRX11379505 | Liposarcoma, Myxoid Adipocyte | 259 / 6462 (4.0%) | 5969 / 64620 (9.2%) | −53.8 | −51.9 | 0.43 |
| JUN SRX7277180 | GM07492 Others | 122 / 6462 (1.9%) | 3877 / 64620 (6.0%) | −53.8 | −51.9 | 0.31 |
| FOXA1 SRX11222442 | MCF-7 Breast | 93 / 6462 (1.4%) | 3383 / 64620 (5.2%) | −53.7 | −51.8 | 0.27 |
| FOXA2 SRX11650944 | hESC derived pancreatic cells Pluripotent stem cell | 122 / 6462 (1.9%) | 3872 / 64620 (6.0%) | −53.6 | −51.7 | 0.32 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 97 / 6462 (1.5%) | 3450 / 64620 (5.3%) | −53.5 | −51.6 | 0.28 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 163 / 6462 (2.5%) | 4524 / 64620 (7.0%) | −53.4 | −51.5 | 0.36 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 265 / 6462 (4.1%) | 6036 / 64620 (9.3%) | −53.3 | −51.5 | 0.44 |
| ISL1 SRX16495323 | SK-N-SH Neural | 30 / 6462 (0.5%) | 2145 / 64620 (3.3%) | −53.2 | −51.3 | 0.14 |
| EP300 SRX22550927 | CDS1 Bone | 229 / 6462 (3.5%) | 5504 / 64620 (8.5%) | −53.1 | −51.2 | 0.42 |
| FOXA1 SRX3923516 | MCF-7 Breast | 104 / 6462 (1.6%) | 3551 / 64620 (5.5%) | −53.0 | −51.1 | 0.29 |
| RELA SRX7054617 | HAEC Cardiovascular | 176 / 6462 (2.7%) | 4707 / 64620 (7.3%) | −53.0 | −51.1 | 0.37 |
| CEBPB SRX1027438 | Mesenchymal stem cells Others | 195 / 6462 (3.0%) | 4994 / 64620 (7.7%) | −52.9 | −51.1 | 0.39 |
| FOXA2 SRX3230382 | Hep G2 Liver | 204 / 6462 (3.2%) | 5127 / 64620 (7.9%) | −52.8 | −50.9 | 0.40 |
| DMC1 SRX663450 | Testis Gonad | 225 / 6462 (3.5%) | 586 / 64620 (0.9%) | −52.8 | −50.9 | 3.84 |
| Epitope tags SRX392692 | T3M-1 Cl-10 Others | 84 / 6462 (1.3%) | 49 / 64620 (0.1%) | −52.8 | −50.9 | 17.14 |
| SNAI2 SRX476926 | Keratinocytes Epidermis | 679 / 6462 (10.5%) | 3469 / 64620 (5.4%) | −52.7 | −50.8 | 1.96 |
| Epitope tags SRX1457740 | 293 Kidney | 353 / 6462 (5.5%) | 1289 / 64620 (2.0%) | −52.6 | −50.7 | 2.74 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 143 / 6462 (2.2%) | 4177 / 64620 (6.5%) | −52.5 | −50.7 | 0.34 |
| SMARCA4 SRX8588624 | Pulmonary artery endothelial cells Cardiovascular | 265 / 6462 (4.1%) | 6002 / 64620 (9.3%) | −52.5 | −50.6 | 0.44 |
| ESR1 SRX2897217 | Breast cancer cells Breast | 373 / 6462 (5.8%) | 1413 / 64620 (2.2%) | −52.5 | −50.6 | 2.64 |
| FOXA1 SRX3931055 | MCF-7 Breast | 127 / 6462 (2.0%) | 3918 / 64620 (6.1%) | −52.4 | −50.5 | 0.32 |
| FOXA1 SRX6878604 | LNCAP Prostate | 122 / 6462 (1.9%) | 3832 / 64620 (5.9%) | −52.4 | −50.5 | 0.32 |
| FOXA1 SRX11222441 | MCF-7 Breast | 113 / 6462 (1.7%) | 3679 / 64620 (5.7%) | −52.3 | −50.4 | 0.31 |
| ERG SRX026657 | Acute promyelocytic leukemia Blood | 709 / 6462 (11.0%) | 3699 / 64620 (5.7%) | −52.3 | −50.4 | 1.92 |
| SUPT5H SRX7677724 | DLD-1 Digestive tract | 597 / 6462 (9.2%) | 2897 / 64620 (4.5%) | −52.2 | −50.3 | 2.06 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 139 / 6462 (2.2%) | 4102 / 64620 (6.3%) | −52.1 | −50.3 | 0.34 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 141 / 6462 (2.2%) | 4133 / 64620 (6.4%) | −52.1 | −50.3 | 0.34 |
| NANOG SRX5286326 | hESC WIBR2 Pluripotent stem cell | 130 / 6462 (2.0%) | 3952 / 64620 (6.1%) | −52.1 | −50.3 | 0.33 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 163 / 6462 (2.5%) | 4478 / 64620 (6.9%) | −52.1 | −50.2 | 0.36 |
| Epitope tags SRX8030771 | 293 Kidney | 608 / 6462 (9.4%) | 2977 / 64620 (4.6%) | −52.1 | −50.2 | 2.04 |
| SMARCA4 SRX5716469 | Neural progenitor cells Neural | 97 / 6462 (1.5%) | 3404 / 64620 (5.3%) | −52.1 | −50.2 | 0.28 |
| EP300 ERX626821 | U-937 Blood | 457 / 6462 (7.1%) | 1951 / 64620 (3.0%) | −52.1 | −50.2 | 2.34 |
| ARID1A SRX5679788 | 12Z Others | 60 / 6462 (0.9%) | 2730 / 64620 (4.2%) | −52.1 | −50.2 | 0.22 |
| ESR1 SRX4451199 | MCF-7 Breast | 195 / 6462 (3.0%) | 451 / 64620 (0.7%) | −52.0 | −50.1 | 4.32 |
| SUZ12 SRX10184495 | K-562 Blood | 752 / 6462 (11.6%) | 4023 / 64620 (6.2%) | −52.0 | −50.1 | 1.87 |
| NKX2-1 SRX2164786 | A549 Lung | 251 / 6462 (3.9%) | 5778 / 64620 (8.9%) | −52.0 | −50.1 | 0.43 |
| NANOG SRX3288567 | hESC H9 Pluripotent stem cell | 51 / 6462 (0.8%) | 2554 / 64620 (4.0%) | −51.9 | −50.0 | 0.20 |
| FOXA1 SRX028635 | MCF-7 Breast | 71 / 6462 (1.1%) | 2936 / 64620 (4.5%) | −51.9 | −50.0 | 0.24 |
| FOXA1 SRX5323846 | MCF-7 Breast | 50 / 6462 (0.8%) | 2532 / 64620 (3.9%) | −51.9 | −50.0 | 0.20 |
| RELA SRX2207671 | HUVEC Cardiovascular | 72 / 6462 (1.1%) | 2951 / 64620 (4.6%) | −51.8 | −50.0 | 0.24 |
| Epitope tags SRX15939724 | RD Muscle | 133 / 6462 (2.1%) | 3990 / 64620 (6.2%) | −51.8 | −50.0 | 0.33 |
| EP300 SRX24299742 | hESC H9 Pluripotent stem cell | 639 / 6462 (9.9%) | 3205 / 64620 (5.0%) | −51.8 | −49.9 | 1.99 |
| SMARCC1 SRX11379511 | Liposarcoma, Myxoid Adipocyte | 202 / 6462 (3.1%) | 5056 / 64620 (7.8%) | −51.8 | −49.9 | 0.40 |
| BRD4 SRX23813261 | C4-2B Prostate | 488 / 6462 (7.6%) | 2160 / 64620 (3.3%) | −51.8 | −49.9 | 2.26 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 143 / 6462 (2.2%) | 4147 / 64620 (6.4%) | −51.7 | −49.9 | 0.34 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 156 / 6462 (2.4%) | 4355 / 64620 (6.7%) | −51.7 | −49.8 | 0.36 |
| FOXA1 SRX9604647 | LNCAP Prostate | 232 / 6462 (3.6%) | 5493 / 64620 (8.5%) | −51.7 | −49.8 | 0.42 |
| RELA SRX7054663 | HAEC Cardiovascular | 126 / 6462 (1.9%) | 3867 / 64620 (6.0%) | −51.5 | −49.6 | 0.33 |
| EP300 SRX11470503 | Mesenchymal stem cells Others | 161 / 6462 (2.5%) | 4417 / 64620 (6.8%) | −51.3 | −49.5 | 0.36 |
| Epitope tags SRX12024485 | Polycystic kidney Kidney | 975 / 6462 (15.1%) | 5752 / 64620 (8.9%) | −51.3 | −49.5 | 1.70 |
| ATF1 SRX11470442 | Mesenchymal stem cells Others | 193 / 6462 (3.0%) | 4902 / 64620 (7.6%) | −51.2 | −49.4 | 0.39 |
| FOXA1 SRX1389379 | CFPAC-1 Pancreas | 101 / 6462 (1.6%) | 3445 / 64620 (5.3%) | −51.2 | −49.4 | 0.29 |
| Epitope tags SRX5770333 | HCT 116 Digestive tract | 479 / 6462 (7.4%) | 2114 / 64620 (3.3%) | −51.1 | −49.3 | 2.27 |
| KDM5A SRX23740438 | SUM 149PT Breast | 640 / 6462 (9.9%) | 3228 / 64620 (5.0%) | −51.1 | −49.3 | 1.98 |
| RBM22 SRX10977335 | K-562 Blood | 183 / 6462 (2.8%) | 405 / 64620 (0.6%) | −51.0 | −49.1 | 4.52 |
| Epitope tags SRX392691 | T3M-1 Cl-10 Others | 87 / 6462 (1.3%) | 61 / 64620 (0.1%) | −50.9 | −49.1 | 14.26 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 291 / 6462 (4.5%) | 6301 / 64620 (9.8%) | −50.9 | −49.0 | 0.46 |
| FOXA1 SRX6878606 | LNCAP Prostate | 71 / 6462 (1.1%) | 2904 / 64620 (4.5%) | −50.9 | −49.0 | 0.24 |
| AR SRX9468652 | LNCAP Prostate | 136 / 6462 (2.1%) | 4006 / 64620 (6.2%) | −50.8 | −49.0 | 0.34 |
| ZNF768 SRX10478010 | Hep G2 Liver | 1102 / 6462 (17.1%) | 6780 / 64620 (10.5%) | −50.8 | −48.9 | 1.63 |
| FOXA1 SRX1885185 | LNCAP Prostate | 111 / 6462 (1.7%) | 3591 / 64620 (5.6%) | −50.7 | −48.8 | 0.31 |
| Epitope tags SRX15939725 | RD Muscle | 118 / 6462 (1.8%) | 3710 / 64620 (5.7%) | −50.7 | −48.8 | 0.32 |
| FOXA1 SRX5323845 | MCF-7 Breast | 49 / 6462 (0.8%) | 2473 / 64620 (3.8%) | −50.6 | −48.8 | 0.20 |
| FOXA1 SRX6878603 | LNCAP Prostate | 172 / 6462 (2.7%) | 4563 / 64620 (7.1%) | −50.6 | −48.8 | 0.38 |
| SMARCA4 SRX8588626 | Pulmonary artery endothelial cells Cardiovascular | 199 / 6462 (3.1%) | 4968 / 64620 (7.7%) | −50.6 | −48.8 | 0.40 |
| ESR1 SRX10365536 | MCF-7 Breast | 86 / 6462 (1.3%) | 3162 / 64620 (4.9%) | −50.6 | −48.7 | 0.27 |
| JUND SRX699738 | HCASMC Cardiovascular | 211 / 6462 (3.3%) | 5143 / 64620 (8.0%) | −50.6 | −48.7 | 0.41 |
| FOXA1 SRX1161203 | T-47D Breast | 116 / 6462 (1.8%) | 3672 / 64620 (5.7%) | −50.6 | −48.7 | 0.32 |
| FOXA1 SRX9604646 | LNCAP Prostate | 214 / 6462 (3.3%) | 5180 / 64620 (8.0%) | −50.4 | −48.6 | 0.41 |
| CEBPB SRX7807103 | Adipocytes Adipocyte | 146 / 6462 (2.3%) | 4148 / 64620 (6.4%) | −50.4 | −48.6 | 0.35 |
| FOXA2 SRX11650948 | hESC derived pancreatic cells Pluripotent stem cell | 129 / 6462 (2.0%) | 3875 / 64620 (6.0%) | −50.4 | −48.5 | 0.33 |
| EP300 SRX24299743 | hESC H9 Pluripotent stem cell | 615 / 6462 (9.5%) | 3068 / 64620 (4.7%) | −50.4 | −48.5 | 2.00 |
| FOXA1 SRX9604645 | LNCAP Prostate | 222 / 6462 (3.4%) | 5295 / 64620 (8.2%) | −50.3 | −48.5 | 0.42 |
| FOXA1 SRX1787653 | MCF-7 Breast | 126 / 6462 (1.9%) | 3824 / 64620 (5.9%) | −50.3 | −48.4 | 0.33 |
| ESR1 SRX7624156 | MCF-7 Breast | 255 / 6462 (3.9%) | 5767 / 64620 (8.9%) | −50.3 | −48.4 | 0.44 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 143 / 6462 (2.2%) | 4099 / 64620 (6.3%) | −50.2 | −48.4 | 0.35 |
| FOXA1 SRX3923518 | MCF-7 Breast | 102 / 6462 (1.6%) | 3425 / 64620 (5.3%) | −50.2 | −48.4 | 0.30 |
| SMARCC1 SRX11379504 | Liposarcoma, Myxoid Adipocyte | 440 / 6462 (6.8%) | 8273 / 64620 (12.8%) | −50.2 | −48.3 | 0.53 |
Showing first 500 of 12550 rows.